50 results
8-K
XLO
Xilio Therapeutics Inc
13 Jun 24
Departure of Directors or Certain Officers
4:15pm
elected and qualified or until his or her earlier resignation, death, or removal. In connection with his election to the Board, Dr. Shannon was appointed
8-K
EX-10.1
h31ekzg c3j
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
nzu 79109ws843kxf3
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-99.2
h11o4 hst8f6ul6j14
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-10.1
yqiqgxjupcp79wzab
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
w24tm1ps31ozgvndm
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-3.1
c4hf1ax cxq9
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
go3iaqhe4pire77
15 Sep 22
Departure of Directors or Certain Officers
4:15pm
8-K
q11ef0uygq
16 Jun 22
Departure of Directors or Certain Officers
7:45am
8-K
EX-10.1
jlystgpbrluk c2ock9x
16 Jun 22
Departure of Directors or Certain Officers
7:45am
DEF 14A
2xj46s72
26 Apr 22
Definitive proxy
4:05pm
10-K
EX-10.20
4x0937tskvmpdc6k
1 Mar 22
Annual report
4:07pm
10-K
r40hi8ql
1 Mar 22
Annual report
4:07pm
8-K
rbbejkhjolhhs
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am